Physician profile
Sergio A Huerta
NPI 1891085882
$5,456.29
in general payments reported to CMS, 2019-2025
17 companies · $525 in 2025
The $525 reported for 2025 was more than what 78% of Addiction Medicine (Internal Medicine) providers received nationally (typical 2025 total: $124).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $351 · 2020: $3,537 · 2021: $105 · 2022: $184 · 2023: $337 · 2024: $416 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,278.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mdd US Operations, LLC | $3,278.00 | 2020 | |
| Indivior INC. | $478.81 | 2019-2025 | Sublocade |
| Braeburn INC. | $417.74 | 2023-2025 | Brixadi |
| Astrazeneca Pharmaceuticals Lp | $357.40 | 2023-2025 | Farxiga, Airsupra |
| Lilly USA, LLC | $265.13 | 2020-2025 | Jardiance |
| Gilead Sciences, INC. | $205.01 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $150.37 | 2020-2023 | Jardiance |
| Uswm, LLC | $58.91 | 2022-2023 | Lucemyra, Zimhi |
| Amarin Pharma, INC. | $49.18 | 2020 | |
| Xeris Pharmaceuticals, INC. | $46.46 | 2020-2023 | Gvoke Hypopen |
| Axsome Therapeutics, INC. | $41.13 | 2025 | Auvelity |
| Novo Nordisk INC | $33.74 | 2025 | |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Organon LLC | $14.92 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.06 | 2025 | Caplyta |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $13.24 | 2022 | |
| Genentech USA, INC. | $11.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergio Huerta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.